Source comparison
BPC-157 Study: Clinical Evidence Comparison
Preclinical (rodent) Tendon transection Tensile strength, collagen density, healing time 30–50% improvement vs saline; 14–21 day healing vs 28+ day controls High internal validity; reproducible across labs Moderate. Mechanism demonstrated but species differenc
This comparison does not assign a generated winner or score.
- Preclinical (rodent)
- Tendon transection
- Tensile strength, collagen density, healing time
- 30–50% improvement vs saline; 14–21 day healing vs 28+ day controls
- High internal validity; reproducible across labs
- Moderate. Mechanism demonstrated but species differences unknown
- Chemical colitis (acetic acid, TNBS)
- Macroscopic damage score, histological grade, inflammatory markers
- 60–70% reduction in damage scores; decreased TNF-α and IL-6
- High internal validity; dose-response shown
- Moderate. GI healing translates better than musculoskeletal but still rodent-only
- Muscle crush injury
- Functional recovery, creatine kinase levels, histological repair
- Faster return to baseline function; reduced necrosis and infiltration
- Moderate. Functional tests subjective in rodents
- Low to moderate. Muscle injury mechanisms differ significantly across species
- Case series (human)
- Various soft tissue injuries
- Patient-reported outcomes, return to activity
- Anecdotal improvement; no controls; high placebo risk
- Very low. Uncontrolled observational data
- Insufficient. Hypothesis-generating only
- In vitro (cell culture)
- Fibroblast and endothelial cell assays
- Proliferation rate, VEGF expression, collagen synthesis
- Dose-dependent increase in all markers at 1–10 mcg/mL concentrations
- Moderate. Mechanism confirmation
- Low. Cell culture doesn't model systemic complexity